Literature DB >> 23051939

Behavioural and neurochemical comparison of chronic intermittent cathinone, mephedrone and MDMA administration to the rat.

Sinead E Shortall1, Alice E Macerola, Rabbi T R Swaby, Rebecca Jayson, Chantal Korsah, Katharine E Pillidge, Peter M Wigmore, Francis J P Ebling, A Richard Green, Kevin C F Fone, Madeleine V King.   

Abstract

The synthetic cathinone derivative, mephedrone, is a controlled substance across Europe. Its effects have been compared by users to 3,4-methylenedioxymethamphetamine (MDMA), but little data exist on its pharmacological properties. This study compared the behavioural and neurochemical effects of mephedrone with cathinone and MDMA in rats. Young-adult male Lister hooded rats received i.p. cathinone (1 or 4 mg/kg), mephedrone (1, 4 or 10mg/kg) or MDMA (10mg/kg) on two consecutive days weekly for 3 weeks or as a single acute injection (for neurochemical analysis). Locomotor activity (LMA), novel object discrimination (NOD), conditioned emotional response (CER) and prepulse inhibition of the acoustic startle response (PPI) were measured following intermittent drug administration. Dopamine, 5-hydroxytryptamine (5-HT) and their major metabolites were measured in striatum, frontal cortex and hippocampus by high performance liquid chromatography 7 days after intermittent dosing and 2h after acute injection. Cathinone (1, 4 mg/kg), mephedrone (10mg/kg) and MDMA (10mg/kg) induced hyperactivity following the first and sixth injections and sensitization to cathinone and mephedrone occurred with chronic dosing. All drugs impaired NOD and mephedrone (10mg/kg) reduced freezing in response to contextual re-exposure during the CER retention trial. Acute MDMA reduced hippocampal 5-HT and 5-HIAA but the only significant effect on dopamine, 5-HT and their metabolites following chronic dosing was altered hippocampal 3,4-dihydroxyphenylacetic acid (DOPAC), following mephedrone (4, 10mg/kg) and MDMA. At the doses examined, mephedrone, cathinone, and MDMA induced similar effects on behaviour and failed to induce neurotoxic damage when administered intermittently over 3 weeks.
Copyright © 2012 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  5-HT; Cathinone; Dopamine; Locomotion; MDMA; Mephedrone

Mesh:

Substances:

Year:  2012        PMID: 23051939     DOI: 10.1016/j.euroneuro.2012.09.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  34 in total

Review 1.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Authors:  Christopher L German; Annette E Fleckenstein; Glen R Hanson
Journal:  Life Sci       Date:  2013-08-02       Impact factor: 5.037

Review 2.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

3.  Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats.

Authors:  Ryan A Gregg; Michael H Baumann; John S Partilla; Julie S Bonano; Alexandre Vouga; Christopher S Tallarida; Venkata Velvadapu; Garry R Smith; M Melissa Peet; Allen B Reitz; S Stevens Negus; Scott M Rawls
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

4.  Analysis of neurotransmitter levels in addiction-related brain regions during synthetic cathinone self-administration in male Sprague-Dawley rats.

Authors:  Julie A Marusich; Elaine A Gay; Bruce E Blough
Journal:  Psychopharmacology (Berl)       Date:  2018-09-06       Impact factor: 4.530

5.  Sensitization to the motor stimulant effects of 3,4-methylenedioxypyrovalerone (MDPV) and cross-sensitization to methamphetamine in rats.

Authors:  Lucas R Watterson; Peter R Kufahl; Sara B Taylor; Natali E Nemirovsky; M Foster Olive
Journal:  J Drug Alcohol Res       Date:  2016-05

6.  Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.

Authors:  Michael D Berquist; Haily K Traxler; Alyssa M Mahler; Lisa E Baker
Journal:  Drug Alcohol Depend       Date:  2016-05-09       Impact factor: 4.492

Review 7.  Neurotoxicology of Synthetic Cathinone Analogs.

Authors:  Mariana Angoa-Pérez; John H Anneken; Donald M Kuhn
Journal:  Curr Top Behav Neurosci       Date:  2017

8.  Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.

Authors:  Alexandre Vouga; Ryan A Gregg; Maryah Haidery; Anita Ramnath; Hassan K Al-Hassani; Christopher S Tallarida; David Grizzanti; Robert B Raffa; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

Review 9.  Behavioral pharmacology of designer cathinones: a review of the preclinical literature.

Authors:  Ryan A Gregg; Scott M Rawls
Journal:  Life Sci       Date:  2013-11-11       Impact factor: 5.037

10.  Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.

Authors:  S E Shortall; A R Green; K M Swift; K C F Fone; M V King
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.